HealthDay.com
High-Riding Patella Seen in ACL Reconstruction, Uninjured Contralateral Knees
Articular contact was 7.6 mm higher on femoral trochlea in ACLR, contralateral knees due to 8.9-mm longer patellar tendon
Aquablation Appears to Be Safe, Effective for Enlarged Prostates
Benefits seen for retrograde ejaculation, urinary incontinence, with overall symptom relief and safety similar to that seen with laser surgery
Six Months of Breastfeeding Tied to Lower Odds of Developmental Delays
Benefits seen in attainment of language and social or motor developmental milestones
Long-Term Gantenerumab May Slow Decline in Dominantly Inherited Alzheimer Disease
Hazard ratio for clinical decline in Clinical Dementia Rating-Sum of Boxes was 0.53 for those treated with gantenerumab the longest
Guidelines Developed for Management of Gastric Premalignant Conditions
Evidence insufficient for making recommendation on upper endoscopic screening or gastric cancer/GPMC detection in high-risk patients
Disparities Identified in Leukemia Incidence, Mortality in Florida
Odds of leukemia-related mortality higher in rural counties and urban neighborhoods with lower socioeconomic status
Molecular Residual Disease Analysis May Predict Disease Recurrence After Lung Cancer Resection
Molecular residual disease precedes DFS events in patients receiving osimertinib, placebo; most events occur after osimertinib discontinuation or completion
FDA Approves Tremfya for Active Crohn Disease in Adults
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease